Word

SOSEI HEPTARES

Status

Registered

Status Code

700

Status Date

Tuesday, August 30, 2022

Serial Number

79288175

Registration Number

6829584

Registration Date

Tuesday, August 30, 2022

Mark Type

4000

Filing Date

Thursday, April 9, 2020

Published for Opposition

Tuesday, June 14, 2022

Trademark Owner History

Sosei Group Corporation - Original Registrant

Classifications

5 Biological products for medical use in chemical and biological drug discovery, lead identification and diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological products for therapeutic purposes, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; proteins for medical use in chemical and biological drug discovery, lead identification and diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; medicines, namely, diagnostic preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; cleaning agent for medical use, namely, medical cleansers for skin wounds; biological formulation for medical use in developing chemical and biological pharmaceutical products, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological formulation for medical use in identifying lead chemical and biological products, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological formulation for medical diagnostic use, namely, diagnostic preparations for medical use; biological formulation for therapeutic use, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; proteins and G-protein-coupled receptors for medical use in drug discovery; biologicals and small chemical entities, including proteins, G-protein-coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for therapeutic purposes, namely, diagnostic preparations for medical use; proteins, G-protein-coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for use in medical diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; medical oiled paper; drug delivery agents in the form of edible pharmaceutical wafers for wrapping powdered pharmaceuticals; gauze for dressings; specialized capsules for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; eye patches for medical purposes, ear bandages; menstrual bands being sanitary pads; menstrual tampons; menstrual napkins, namely, menstrual symptom treatment preparations; menstrual underwear, namely, panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; collodion for pharmaceutical purposes; cotton swabs for medical purposes; breast-nursing pads

1 chemical products and proteins for manufacturing chemical and biological pharmaceutical products; chemical products and proteins for the scientific research of chemical and biological pharmaceutical products; chemical products and proteins for diagnostic use, except medical or veterinary uses, namely, diagnostic preparations for scientific use; proteins and specifically proteins in the nature of G-protein-coupled receptors for manufacturing pharmaceutical products; proteins and specifically proteins in the nature of G-protein-coupled receptors, for the scientific research of pharmaceutical products; chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics, namely, chemical and biological preparations for use in scientific purposes; proteins and G-protein-coupled receptors for drug discovery purpose, namely, proteins and biological preparations for use in scientific research; chemicals preparations and biologicals preparations for scientific research purposes, being proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics; proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, all for use in scientific pharmaceutical research and scientific pharmaceutical research in the nature of drug discovery purposes

42 Bio-technology, pharmaceutical and scientific testing, research and development; biological research services; research and development services in the pharmaceutical and biopharmaceutical fields;, research and development services in the pharmaceutical and biopharmaceutical fields, namely, in the field of technologies related to proteins and G-protein-coupled receptors; research services in biology and chemistry fields; pharmaceutical research services in chemical and biological drug discovery and development; scientific and pharmaceutical research and development services for identifying lead chemical compounds; scientific analysis and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; pharmaceutical research and development in the nature of research, creation, development and provision of chemical and biological drug targets for non-medical scientific screening purposes; technical diagnostic testing services, namely, scientific and pharmaceutical research and development; scientific research, analysis and examination for identification of compounds through automated screening processes, being scientific and pharmaceutical research and development; research and development services in chemical and biological pharmaceutical development; provision of information, advisory services and consultancy relating to the aforesaid services

The English translation of "SOSEI" in the mark is "DO AS YOU WISH".

Trademark Events

Dec 27, 2022

Final Decision Transaction Processed By Ib

Dec 7, 2022

Final Disposition Notice Sent To Ib

Dec 7, 2022

Final Disposition Processed

Nov 30, 2022

Final Disposition Notice Created, To Be Sent To Ib

Nov 4, 2022

New Representative At Ib Received

Aug 30, 2022

Notice Of Registration Confirmation Emailed

Aug 30, 2022

Registered-Principal Register

Jul 5, 2022

Notification Processed By Ib

Jun 14, 2022

Official Gazette Publication Confirmation E-Mailed

Jun 14, 2022

Published For Opposition

Jun 8, 2022

Notification Of Possible Opposition Sent To Ib

Jun 8, 2022

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

May 25, 2022

Notification Of Notice Of Publication E-Mailed

May 6, 2022

Approved For Pub - Principal Register

May 5, 2022

Teas/Email Correspondence Entered

May 5, 2022

Correspondence Received In Law Office

May 5, 2022

Assigned To Lie

Apr 30, 2022

Teas Response To Suspension Inquiry Received

Mar 14, 2022

Report Completed Suspension Check Case Still Suspended

Dec 19, 2021

Notification Of Possible Opposition - Processed By Ib

Dec 1, 2021

Notification Of Possible Opposition Sent To Ib

Dec 1, 2021

Notification Of Possible Opposition Created, To Be Sent To Ib

Sep 9, 2021

Correspondence E-Mailed

Sep 9, 2021

Suspension Letter Written

Sep 9, 2021

Teas/Email Correspondence Entered

Sep 9, 2021

Correspondence Received In Law Office

Sep 9, 2021

Teas Request For Reconsideration Received

Mar 9, 2021

Notification Of Final Refusal Emailed

Mar 9, 2021

Final Refusal E-Mailed

Mar 9, 2021

Final Refusal Written

Mar 5, 2021

Examiner's Amendment Entered

Mar 5, 2021

Notification Of Examiners Amendment E-Mailed

Mar 5, 2021

Examiners Amendment E-Mailed

Mar 5, 2021

Examiners Amendment -Written

Feb 4, 2021

Teas/Email Correspondence Entered

Feb 4, 2021

Correspondence Received In Law Office

Feb 4, 2021

Teas Response To Office Action Received

Aug 30, 2020

Refusal Processed By Ib

Aug 11, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Aug 11, 2020

Refusal Processed By Mpu

Jul 3, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Jul 2, 2020

Non-Final Action Written

Jun 30, 2020

Non-Final Action (Ib Refusal) Withdrawn For Review

Jun 30, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Jun 30, 2020

Application Filing Receipt Mailed

Jun 29, 2020

Non-Final Action Written

Jun 26, 2020

Assigned To Examiner

Jun 26, 2020

New Application Office Supplied Data Entered In Tram

Jun 25, 2020

Sn Assigned For Sect 66a Appl From Ib